Floatz logo

Letrozole

Treatment

University Hospital, Strasbourg, FranceSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

9 Active assets in the Treatment cohort.

Asset / SponsorPhaseRating
Sodium Oligomannate
First Affiliated Hospital Xi'an Jiaotong University
Phase 4B
CIS-DIAMMINEDICHLOROPLATINUM II
Peking Union Medical College Hospital
Phase 2B
Capecitabine
Henan Cancer Hospital
Phase 2CCC
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
University Hospital, Strasbourg, France
Phase 2CCC
Vinorelbine
Henan Cancer Hospital
Phase 2CCC

View all 10 →

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →